Alok Suresh Pawaskar

Learn More
When it comes to cancer, one can expect the unexpected. The clinical presentations can be very bizarre. One of these uncommon presentations is monoarticular arthritis. The age group affected by cancer and arthritis are similar. However, the possibility of joint pain being secondary to metastatic involvement does not come to mind easily. In this report, a(More)
AIMS AND OBJECTIVES The aim of this study was to retrospectively correlate FDG uptake in primary Ewing sarcoma family of tumors (ESFT) with tumor behavior, and to evaluate whether FDG PET can be used to predict response to neoadjuvant chemotherapy (NACT) in this patient group. METHODS Out of the total 54 patients of recently diagnosed ESFT who underwent(More)
FDG-PET/CT is a potentially useful imaging modality in the setting of Carcinoma of Unknown Primary (CUP) from various aspects. The central question is detection of site of primary, where most studies have documented the pooled sensitivity and specificity of FDG PET/CT in the range of 80%-85% and a tumor detection rate (after the failure of conventional(More)
Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography (F-18 FDG PET-CT) is the modality of choice for the diagnosis, staging, and restaging of many malignancies. The importance of eliminating false positives cannot be underestimated because they can dramatically alter the clinical course. We present a case of benign uptake in the(More)
OBJECTIVE To identify coronary artery disease (CAD) in asymptomatic diabetics with the help of myocardial perfusion single photon emission computed tomography (MPS), a non-invasive imaging modality and its correlation in diabetics with or without microalbuminuria. METHODS This study included 99 patients in the age group of 30 to 80 years who were(More)
BACKGROUND To evaluate the advantages of contrast enhanced F-18-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-contrast enhanced CT [CECT]) when used as an initial imaging modality in patients presenting with metastatic malignancy of undefined primary origin (MUO). MATERIALS AND METHODS A total of 243 patients with fine(More)
  • 1